Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: Cause for concern?

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 3, 2013, Pages 726-727

  Shekar, Kiran ^a   Roberts, Jason A ^a   Ghassabian, Sussan ^a   Mullany, Daniel V ^a   Wallis, Steven C ^a   Smith, Maree T ^a   Fraser, John F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

ICU; Renal replacement therapy; Therapeutic drug monitoring; Toxicity; Treatment failure

Indexed keywords

MEROPENEM;

CONTINUOUS HEMOFILTRATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MEGADOSE; EXTRACORPOREAL OXYGENATION; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE ORGAN FAILURE; OXYGENATOR; PNEUMONIA; PSEUDOMONAS PNEUMONIA; RESPIRATORY FAILURE; SEPTICEMIA;

ADULT; ANTI-BACTERIAL AGENTS; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; PLASMA; THIENAMYCINS;

EID: 84873599059     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks435     Document Type: Letter

References (10)

1. Roberts JA, Kirkpatrick CM, Roberts MS et al. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother 2009; 64: 142-50.
2. Bilgrami I, Roberts JA, Wallis SC et al. Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration. Antimicrob Agents Chemother 2010; 54: 2974-8.
3. Roberts JA, Ulldemolins M, Roberts MS et al. Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents 2010; 36: 332-9.
4. Shekar K, Roberts JA, McDonald CI et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care 2012; 16: R194.
5. Wildschut ED, Ahsman MJ, Allegaert K et al. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010; 36: 2109-16.
6. Alcorn J, McNamara PJ. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 2003; 55: 667-86.
7. Shekar K, Fraser JF, Smith MT et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012; doi:10.1016/j.jcrc.2012.02.013.
8. Shekar K, Mullany DV, Corley A et al. Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardio-respiratory failure. Anaesth Intensive Care 2012; 40: 648-55.
9. Kollef MH, Sherman G, Ward S et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462-74.
10. Shekar K, Fung YL, Diab S et al. Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions. Crit Care Resusc 2012; 14: 105-11.